Tech Company Financing Transactions
Amprion Funding Round
Formation Venture Engineering and Eli Lilly and Company participated in a $6 million Series B funding round for Amprion. The round was announced on 10/9/2024.
Transaction Overview
Company Name
Announced On
10/9/2024
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series B
Investors
Formation Venture Engineering (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand its commercial reach and enable increased R&D investment to further enhance brain disease diagnosis.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
10355 Science Center Drive 240
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Amprion's mission: To revolutionize brain disease diagnosis. Through molecular testing, we aim to accelerate precision medicine for neurodegenerative disorders. As a pioneer in detecting misfolded proteins, we believe precision medicine is the new frontier. We strive to positively impact brain disease diagnosis and treatment as the world population ages rapidly.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Russ Lebovitz
Chief Operating Officer
Ben Vollrath
Chief Scientific Officer
Claudio Soto
Vice President
Sean McEvoy
VP - Bus. Development
Brandt Charters
VP - Finance
Ginger Sedillo
VP - R & D
Luis Concha
VP - Regulatory Affairs
Karen MacLeod
Browse more venture capital transactions:
Prev: 10/9/2024: Paebbl venture capital transaction
Next: 10/9/2024: Proteine Resources venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs